Related Experiment Videos
Propylene oxide: mutagenesis, carcinogenesis and molecular dose
M N Ríos-Blanco1, K Plna, T Faller
1Curriculum in Toxicology, University of North Carolina at Chapel Hill 27599, USA.
Mutation Research
|December 31, 1997
Summary
Propylene oxide (PO) exposure forms DNA adducts, primarily in target tissues like the respiratory tract, not the liver. Molecular dosimetry methods can quantify these adducts, aiding risk assessment for PO carcinogenicity.
Area of Science:
- Toxicology
- Molecular Biology
- Environmental Health
Background:
- Propylene oxide (PO) is a mutagen and carcinogen, inducing tumors at the site of contact in rodents.
- Developing molecular dosimetry methods is crucial for assessing PO exposure risks.
- PO-DNA adducts, specifically N7-(2-hydroxypropyl)guanine (7-HPG), are key biomarkers.
Purpose of the Study:
- To review mutagenic and carcinogenic studies of PO.
- To evaluate methods for quantifying PO-DNA adducts in rodent tissues.
- To assess the persistence of these adducts and their distribution in relation to carcinogenic effects.
Main Methods:
- Inhalation exposure of F344 rats to 500 ppm PO.
- Quantification of N7-(2-hydroxypropyl)guanine (7-HPG) using neutral thermal hydrolysis, GC-HRMS, and 32P-postlabeling.
- Analysis of DNA adducts in nasal, olfactory, and hepatic tissues immediately after exposure and after a 3-day recovery period.
Main Results:
- High levels of 7-HPG adducts were found in respiratory and olfactory tissues, significantly higher than in the liver.
- Adduct levels decreased after a 3-day recovery period but remained detectable.
- No endogenous formation of 7-HPG was observed in control animals.
Conclusions:
- The respiratory tract and olfactory tissues are primary targets for PO-induced DNA alkylation.
- Molecular dosimetry methods effectively quantify PO-DNA adducts, correlating with carcinogenic potential.
- These findings support the use of 7-HPG adducts in risk assessment for propylene oxide exposure.